Main Article Content
hiv screening, hiv testing, hiv detection, hiv infection, human immunodeficiency virus, hiv testing support, routine hiv screening, chronic disease screening, immunodeficiency virus hiv
current methods. Clin Infect Dis 2013;57:712–8.
2. Moyer VA, U.S. Preventive Services Task Force. Screening for HIV: U.S. preventive services task force recommendation statement. Ann Intern Med 2013;159:51–60.
3. Niel Constantine. HIV InSite Knowledge Base: HIV Antibody Assays. Available from: http://hivinsite.ucsf.edu/InSite?page=KB. Accessed Jan 25, 2014.
4. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR: Recommendations and Reports 2006;55(RR–14):1–17.
5. United States Preventive Services Task Force. Screening for HIV: Recommendation Statement [internet]. 2005 [updated 2007 April 2]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf05/hiv/ hivrs.htm. Accessed Jan 21, 2014.
6. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiviral therapy. N Engl J Med 2011;365:493–505.
7. Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 2010;153:778–89.
8. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005;352:570–85.
9. Centre for Disease Control. Vital signs: HIV testing and diagnosis among adults – United States, 2001-2009. MMWR 1010;59:1550–5.
10. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outctherapy (ART)- naïve participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 2008;197:1133–44.